Finance

Lists
600479:SHA
ZhuZhou QianJin Pharmaceutical Co., Ltd
CNÂ¥12.96
-3.07%
(-0.41) 1D
Sep 2, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600479...
Open
CNÂ¥13.24
High
CNÂ¥14.71
Low
CNÂ¥12.90
Mkt. cap
5.98B
Avg. vol.
19.89M
Volume
133.36M
Dividend
2.93%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 30, 2026
P/E ratio
17.87
52-wk high
CNÂ¥14.71
52-wk low
CNÂ¥9.20
EPS
CNÂ¥0.73
Shares outstanding
418.51M
No. of employees
5K
Open
CNÂ¥13.24
High
CNÂ¥14.71
Low
CNÂ¥12.90
Mkt. cap
5.98B
Avg. vol.
19.89M
Volume
133.36M
Dividend
2.93%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 30, 2026
P/E ratio
17.87
52-wk high
CNÂ¥14.71
52-wk low
CNÂ¥9.20
EPS
CNÂ¥0.73
Shares outstanding
418.51M
No. of employees
5K
About ZhuZhou QianJin Pharmaceutical Co., Ltd
CEO-
Employees5.04K
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitecnqjyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
900.34M
910.51M
970.27M
948.03M
Cost of goods sold
450.97M
500.94M
495.55M
469.73M
Cost of revenue
450.97M
500.94M
495.55M
469.73M
Research and development expenses
40.72M
40.70M
38.97M
51.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
327.70M
246.01M
338.40M
290.39M
Operating expense
381.83M
284.40M
391.73M
332.84M
Total operating expenses
832.80M
785.33M
887.28M
802.57M
Operating income
67.54M
125.18M
82.99M
145.46M
Other non operating income
2.30M
-49.38K
-1.87M
-7.46M
EBT including unusual items
104.34M
136.39M
96.56M
136.04M
EBT excluding unusual items
103.38M
131.92M
92.29M
140.48M
Income tax expense
20.14M
18.95M
12.36M
20.33M
Effective tax rate
19.31%
13.89%
12.81%
14.94%
Other operating expenses
6.28M
8.06M
4.60M
944.91K
Net income
59.63M
98.94M
75.00M
105.84M
Net profit margin
6.62%
10.87%
7.73%
11.16%
Earnings per share
-
-
-
-
Interest and investment income
33.55M
6.79M
11.18M
2.48M
Interest expense
-12.27K
-4.13K
-
-
Net interest expenses
33.54M
6.79M
11.18M
2.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
86.59M
144.29M
102.10M
168.38M
Gain or loss from assets sale
8.83K
-1.88M
-
-706.54K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps